Drug-Eluting Stents in the Treatment of Intermediate Lesions. Pooled Analysis From Four Randomized Trials

Journal of the American College of Cardiology

Volumn 47, Issue 11, 2006, Pages 2164-2171

  Moses, Jeffrey W ^a   Stone, Gregg W ^a   Nikolsky, Eugenia ^a   Mintz, Gary S ^a   Dangas, George ^a   Grube, Eberhard ^b   Ellis, Stephen G ^c   Lansky, Alexandra J ^a   Weisz, Giora ^a   Fahy, Martin ^a   Na, Yingbo ^a   Russell, Mary E ^d   Donohoe, Dennis ^e   Leon, Martin B ^a   Mehran, Roxana ^a  

^a NewYork Presbyterian Hospital   (United States)

^b Heart Center Siegburg   (Germany)

^c LERNER RESEARCH INSTITUTE   (United States)

^d BOSTON SCIENTIFIC CORPORATION   (United States)

^e Department of Medical Affairs and Health Ecomomics Worldwide   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN; DRUG; METAL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZATION; RESTENOSIS; REVASCULARIZATION; THROMBOSIS; TREATMENT FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; EQUIPMENT DESIGN; HOSPITALIZATION; META ANALYSIS; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; STENT;

CORONARY RESTENOSIS; EQUIPMENT DESIGN; HEART DISEASES; HUMANS; METALS; PHARMACEUTICAL PREPARATIONS; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; STENTS;

EID: 33745292837     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.01.068     Document Type: Article

References (24)

1. Smith Jr. S.C., Dove J.T., Jacobs A.K., et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary. a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty); endorsed by the Society for Cardiac Angiography and Interventions. Circulation 103 (2001) 3019-3041
2. Fearon W.F., Takagi A., Jeremias A., et al. Use of fractional myocardial flow reserve to assess the functional significance of intermediate coronary stenoses. Am J Cardiol 86 (2000) 1013-1014
3. De Bruyne B., Paulus W.J., and Pijls N.H. Rationale and application of coronary transstenotic pressure gradient measurements. Cathet Cardiovasc Diagn 33 (1994) 250-261
4. Pijls N.H., De Bruyne B., Peels K., et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334 (1996) 1703-1708
5. Briguori C., Anzuini A., Airoldi F., et al. Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve. Am J Cardiol 87 (2001) 136-141
6. Fearon W.F., and Yeung A.C. Evaluating intermediate coronary lesions in the cardiac catheterization laboratory. Rev Cardiovasc Med 4 (2003) 1-7
7. Bech G.J., De Bruyne B., Pijls N.H., et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis. a randomized trial. Circulation 103 (2001) 2928-2934
8. Chamuleau S.A., Meuwissen M., Koch K.T., et al. Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis. Am J Cardiol 89 (2002) 377-380
9. Rieber J., Schiele T.M., Koenig A., et al. Long-term safety of therapy stratification in patients with intermediate coronary lesions based on intracoronary pressure measurements. Am J Cardiol 90 (2002) 1160-1164
10. Berger A., Botman K.J., MacCarthy P.A., et al. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol 46 (2005) 438-442
11. Abizaid A.S., Mintz G.S., Mehran R., et al. Long-term follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings. importance of lumen dimensions. Circulation 100 (1999) 256-261
12. Hoye A., Lemos P.A., Arampatzis C.A., et al. Effectiveness of sirolimus-eluting stent implantation for coronary narrowings <50% in diameter. Am J Cardiol 94 (2004) 112-114
13. Moses J.W., Leon M.B., Popma J.J., et al., SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
14. Holmes Jr. D.R., Leon M.B., Moses J.W., et al. Analysis of 1-year clinical outcomes in the SIRIUS trial. a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 109 (2004) 634-640
15. Stone G.W., Ellis S.G., Cox D.A., et al., TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231 5
16. Stone G.W., Ellis S.G., Cox D.A., et al., TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting Taxus stent. the TAXUS-IV trial. Circulation 109 (2004) 1942-1947
17. Grube E., Sonoda S., Ikeno F., et al. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer. Circulation 109 (2004) 2168-2171
18. Costa R.A., Lansky A.J., Mintz G.S., et al. Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial). Am J Cardiol 95 (2005) 113-116
19. Storger H., Grube E., Hofmann M., Schwarz F., and Haase J. Clinical experiences using everolimus-eluting stents in patients with coronary artery disease. J Interv Cardiol 17 (2004) 387-390
20. Mercado N., Maier W., Boersma E., et al. Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J 24 (2003) 541-551
21. Miller D.D., Donohue T.J., Younis L.T., et al. Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. Circulation 89 (1994) 2150-2160
22. Meuwissen M., de Winter R.J., Chamuleau S.A., et al. Value of C-reactive protein in patients with stable angina pectoris, coronary narrowing (30% to 70%), and normal fractional flow reserve. Am J Cardiol 92 (2003) 702-705
23. Bech G.J., De Bruyne B., Bonnier H.J., et al. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol 31 (1998) 841-847
24. Wang J.C., Normand S.L., Mauri L., and Kuntz R.E. Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation 110 (2004) 278-284